1. Home
  2. ESRT vs MDXG Comparison

ESRT vs MDXG Comparison

Compare ESRT & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Empire State Realty Trust Inc.

ESRT

Empire State Realty Trust Inc.

N/A

Current Price

$4.62

Market Cap

834.5M

Sector

Real Estate

ML Signal

N/A

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

N/A

Current Price

$4.67

Market Cap

672.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ESRT
MDXG
Founded
2011
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
834.5M
672.8M
IPO Year
2012
2007

Fundamental Metrics

Financial Performance
Metric
ESRT
MDXG
Price
$4.62
$4.67
Analyst Decision
Hold
Strong Buy
Analyst Count
6
5
Target Price
$5.40
★ $7.40
AVG Volume (30 Days)
★ 4.5M
976.3K
Earning Date
11-02-2026
10-28-2026
Dividend Yield
★ 3.06%
N/A
EPS Growth
N/A
★ 14.29
EPS
★ N/A
N/A
Revenue
★ $768,270,000.00
$418,630,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$21.78
P/E Ratio
★ N/A
N/A
Revenue Growth
0.05
★ 19.99
52 Week Low
$3.93
$3.03
52 Week High
$8.04
$7.97

Technical Indicators

Market Signals
Indicator
ESRT
MDXG
Relative Strength Index (RSI) 63.54 53.33
Support Level $3.95 $4.37
Resistance Level $5.85 $4.76
Average True Range (ATR) 0.14 0.16
MACD 0.09 -0.02
Stochastic Oscillator 98.47 42.37

Price Performance

Historical Comparison
ESRT
MDXG

About ESRT Empire State Realty Trust Inc.

Empire State Realty Trust Inc is a real estate investment trust (REIT) that owns and operates office, retail, and multifamily properties located in New York City, prominently in Manhattan. Its portfolio includes office and retail space as well as residential units. The company's objective is to maximize cash flow and total returns to its shareholders and to increase the value of the properties. Its reportable segments consist of a real estate segment and an Observatory segment. The majority of revenue is derived from the Real Estate segment, which includes all activities related to the ownership, management, operation, acquisition, redevelopment, repositioning and disposition of its traditional real estate assets.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: